May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Aspects of Color Vision in Duchenne Muscular Dystrophy
Author Affiliations & Notes
  • M.F. Costa
    University of Sao Paulo, Sao Paulo, Brazil
    Psicologia Experimental,
    Núcleo de Neurociências e Comportamento,
  • A.G. F. Oliveira
    University of Sao Paulo, Sao Paulo, Brazil
    Psicologia Experimental,
    Núcleo de Neurociências e Comportamento,
  • C. Feitosa–Santana
    University of Sao Paulo, Sao Paulo, Brazil
    Psicologia Experimental,
    Núcleo de Neurociências e Comportamento,
  • M. Lago
    University of Sao Paulo, Sao Paulo, Brazil
    Psicologia Experimental,
    Núcleo de Neurociências e Comportamento,
  • M. Zatz
    University of Sao Paulo, Sao Paulo, Brazil
    Centro Estudos Genoma Humano – IBUSP,
  • D.F. Ventura
    University of Sao Paulo, Sao Paulo, Brazil
    Psicologia Experimental,
    Núcleo de Neurociências e Comportamento,
  • Footnotes
    Commercial Relationships  M.F. Costa, None; A.G.F. Oliveira, None; C. Feitosa–Santana, None; M. Lago, None; M. Zatz, None; D.F. Ventura, None.
  • Footnotes
    Support  Temático FAPESP, CNPq, CAPES–PROCAD; DFV and MZ are CNPq research fellows
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3700. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.F. Costa, A.G. F. Oliveira, C. Feitosa–Santana, M. Lago, M. Zatz, D.F. Ventura; Aspects of Color Vision in Duchenne Muscular Dystrophy . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3700.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate color vision in DMD subjects and to correlate these findings with the Vignos motor function scale for neuromuscular disorder and with the region of gene deletion.

Methods: : We evaluated 77 subjects with DMD (age 14.6 ±4.5yrs) classified in 3 groups according with their gene deletion: no deletions (n=29); deletion upstream exon 30 (n=8); deletion downstream exon 30 (n=40). Controls were 35 age–matched subjects. Color vision was evaluated with Cambridge Colour Test (CCT) – Trivector and Ellipses protocols, Neitz Anomaloscope, and two plate tests: Ishihara and AO H–R–R plates. Response reliability was assessed in the CCT with catch trials interspersed in the staircases.

Results: : Color vision tests could be performed in 63/77 (81%) of the subjects Poor collaboration and difficulty understanding the instructions prevented test performance in the remaining 14 patients, which had deletion downstream exon 30 (8/14) or no deletions (6/14). Color vision losses measured by the CCT were found in 44/63 (69%) subjects, the majority of which (81%) had a red–green defect, confirmed by the Anomaloscope results (Wilcoxon test – Trivector p= .71; Ellipse p< .98). The AO H–R–R and Ishihara plates were less sensitive, revealing respectively, 2% and 9% of red–green color vision losses; and these results did not correlate with the Rayleigh matches (AO H–R–R p= .006; Ishihara p< .001). Red–green defect was present in 14/23 (60%) subjects with no deletion and in 21/32 (66%) subjects with deletion downstream exon 30. All controls and DMD subjects had 100% correct responses to the catch trials. No correlation was found between the score obtained with the Vignos motor scale and CCT color vision thresholds .

Conclusions: : With the color vision test battery used we observed that red–green losses seem to be more frequent and more severe in subjects with deletions downstream exon 30, which involve the retinal dystrophin isoform Dp260. These findings suggest a secondary effect of the dystrophin mutation in retinal function.

Keywords: color vision • retina • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×